David Schnabel has been the Director & Senior Technical Advisor for the CDC-Kenya HIV Research Programme in Kisumu, Kenya since September 2015. As a medical officer in CDC, Division of HIV/AIDS Prevention (DHAP), Schnabel is the Site Principal Investigator for a number of DAIDS funded network clinical trials including the AMP Study (HPTN 081) and an MSM cohort study (HPTN 075). As the Kisumu Clinical Research Site Leader, he oversees a dynamic multi-network center conducting Phase II and III, HIV and TB, prevention and therapeutic trials. Prior to CDC-Kenya, he completed CDC’s Epidemic Intelligence Service (EIS) Fellowship with primary service at the Maryland Department of Health and Mental Hygiene, Baltimore, USA. As an EIS Officer, he also served in Sierra Leone as District Lead for the Ebola Response Epidemiology Team between August and September, 2014, and the Ebola Vaccine Trial, between March and April, 2015.
Schnabel graduated from Ohio State University, College of Medicine, USA in 2002 and was commissioned as a medical officer in the US Army. After clinical training and duty as a general practitioner at the Tripler Army Medical Center, he completed the Walter Reed Army Institute of Research (WRAIR) Preventive Medicine Residency and an MPh from Johns Hopkins University. After residency, he directed the Department of Emerging Infectious Diseases at the US Army Medical Research Unit in Nairobi, Kenya and conducted influenza, arbovirus and malaria drug resistance public health surveillance, response and research. From 2011 to 2013, he developed the Walter Reed Tanzania Malaria Research Programme as Chief, Department of Field Studies, WRAIR. While at WRAIR, he served as Chair, WRAIR Scientific Steering Committee. In 2013, Schnabel completed an inter-service transfer from the US Army to the Commissioned Corps of the US Public Health Service and currently holds the rank of Commander.